Pyoderma Gangrenosum Secondary to Melanotan

Pyoderma gangreonsum (PG) is a rare neutrophilic dermatosis that presents as a rapidly enlarging ulcer. Although the exact aetiology is unclear, up to half of the cases are linked to a systemic inflammatory disorder such as rheumatological conditions, haematology malignancy, or inflammatory bowel disease. A 65-year-old woman reported utilising Melanotan and subsequently developing ulcerated wounds at the injection sites on her abdomen. Clinically, four wounds were noted with an erythematous edge corresponding to the injection sites of melanotan. A diagnosis of PG was obtained due to the wounds' appearance, progression rate, lack of response to multiple courses of antibiotics, and negative bacteriology, including Panton-Valentine leukocidin <i>Staphylococcus aureus</i>. Topical betamethasone, alongside steroid occlusion tape and prednisolone, was commenced with good effect. Prednisolone was slowly titrated, and topical therapy with Dermovate was initiated. The wounds healed with classic cribriform scars after several months of treatment. Drug-induced PG has rarely been documented. However, melanotan-induced PG has never been reported in the literature before. We hope to highlight this case to increase awareness of the side effects of melanotan.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-12-02
DOI
https://doi.org/10.7759/cureus.98297
Citations
1
Primary Topic
Autoimmune and Inflammatory Disorders
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pyoderma Gangrenosum Secondary to Melanotan

Su Su Htwe, D. Dickson
1 citations
Cureus
Autoimmune and Inflammatory Disorders
1.35
article

Pyoderma Gangrenosum Secondary to Melanotan

Su Su Htwe, D. Dickson
article en
1 citations

Abstract

Pyoderma gangreonsum (PG) is a rare neutrophilic dermatosis that presents as a rapidly enlarging ulcer. Although the exact aetiology is unclear, up to half of the cases are linked to a systemic inflammatory disorder such as rheumatological conditions, haematology malignancy, or inflammatory bowel disease. A 65-year-old woman reported utilising Melanotan and subsequently developing ulcerated wounds at the injection sites on her abdomen. Clinically, four wounds were noted with an erythematous edge corresponding to the injection sites of melanotan. A diagnosis of PG was obtained due to the wounds' appearance, progression rate, lack of response to multiple courses of antibiotics, and negative bacteriology, including Panton-Valentine leukocidin <i>Staphylococcus aureus</i>. Topical betamethasone, alongside steroid occlusion tape and prednisolone, was commenced with good effect. Prednisolone was slowly titrated, and topical therapy with Dermovate was initiated. The wounds healed with classic cribriform scars after several months of treatment. Drug-induced PG has rarely been documented. However, melanotan-induced PG has never been reported in the literature before. We hope to highlight this case to increase awareness of the side effects of melanotan.

CureusVol. 17(12)
Glasgow Royal Infirmary (GB)
Openalex Percentile: Top 14%
Autoimmune and Inflammatory Disorders
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.